Needham & Company Maintains a 'Strong Buy' on Mylan (MYL) and Par Pharmaceutical (PRX)
Tweet Send to a Friend
Needham & Company maintains a 'Strong Buy' on Mylan Inc. (MYL), price target $26.
Needham analyst says, "MYL appears ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says, "MYL appears ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
